Rozemeijer, Rik <br/><br/>
Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.  [electronic resource] 

 -  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions  02 2018 
 - 410-416 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1522-726X 
<br/><br/><label>Standard No.: </label>10.1002/ccd.27142  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Agents--administration & dosage<br/>Coronary Artery Disease--diagnostic imaging<br/>Drug-Eluting Stents<br/>Equivalence Trials as Topic<br/>Humans<br/>Multicenter Studies as Topic<br/>Percutaneous Coronary Intervention--adverse effects<br/>Prospective Studies<br/>Prosthesis Design<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Sirolimus--administration & dosage<br/>Time Factors<br/>Treatment Outcome